OpGen Investor Relations Material

OpGen, Inc. is a precision medicine company that engages in developing and commercializing molecular microbiology solutions in the United States and internationally. The Company provides access to pathogen detection platforms, including Biotype-Specific Polymerase Chain Reaction (PCR) assays to rapidly identify pathogens, as well as other molecular applications for use in detecting bacterial, viral and fungal pathogens found in blood cultures. The company was incorporated in 2001 and is headquartered in Rockville, Maryland.